Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.5.0.2
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2016
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Three Months Ended
 June 30,		   Six Months Ended
 June 30,
Franchised clinics:   2016   2015   2016   2015
 Clinics open at beginning of period     277       241       265       242  
 Opened during the period     11       10       25       23  
 Acquired during the period     (6 )     (11 )     (6 )     (21 )
 Closed during the period     (2 )     (1 )     (4 )     (5 )
 Clinics in operation at the end of the period     280       239       280       239  
    Three Months Ended
 June 30,		   Six Months Ended
 June 30,
Company-owned or managed clinics:   2016   2015   2016   2015
 Clinics open at beginning of period     54       12       47       4  
 Opened during the period     1       -       8       -  
 Acquired during the period     6       11       6       21  
 Closed during the period     -       -       -       (2 )
 Clinics in operation at the end of the period     61       23       61       23  
                                 
 Total clinics in operation at the end of the period     341       262       341       262  
                                 
 Clinics licenses sold but not yet developed     134       230       134       230  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Three Months Ended
June 30,		   Six Months Ended
June 30,
    2016   2015   2016   2015
                 
Net loss   $ (3,261,382 )   $ (1,855,870 )   $ (6,786,515 )   $ (3,759,593 )
                                 
Weighted average common shares outstanding - basic     12,672,974       9,768,230       12,620,438       9,734,115  
Effect of dilutive securities:                                
Stock options     -       -       -       -  
Weighted average common shares outstanding - diluted     12,672,974       9,768,230       12,620,438       9,734,115  
                                 
Basic and diluted loss per share   $ (0.26 )   $ (0.19 )   $ (0.54 )   $ (0.39 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Three Months Ended
June 30,		   Six Months Ended
June 30,
    2016   2015   2016   2015
Unvested restricted stock     151,806       116,818       151,806       453,846  
Stock options     787,955       271,895       787,955       376,275  
Warrants     90,000       90,000       90,000       90,000